Publication Name	World Journal of Diabetes
Manuscript ID	69392
Country	Serbia

Received	2021-06-28 17:47
Peer-Review Started	2021-06-28 17:52
First Decision by Editorial Office Director	2021-07-15 17:57
Return for Revision	2021-07-15 17:57
Revised	2021-07-24 14:49
Publication Fee Transferred
Second Decision by Editor	2021-08-06 03:17
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2021-08-06 05:57
Articles in Press	2021-08-06 05:57
Edit the Manuscript by Language Editor	2021-08-17 22:37
Typeset the Manuscript	2021-10-11 04:17
Publish the Manuscript Online	2021-10-13 08:37

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
Manuscript Source	Invited Manuscript
All Author List	Milica M Borovcanin, Katarina Vesic, Milena Jovanovic and Natasa R Mijailovic
Funding Agency and Grant Number	Funding Agency Grant Number Ministry of Science and Technological Development of the Republic of Serbia 175069 Faculty of Medical Sciences, University of Kragujevac JP 15-05
Corresponding Author	Milica M Borovcanin, MD, PhD, Associate Professor, Department of Psychiatry, University of Kragujevac, Serbia, Faculty of Medical Sciences, 69 Svetozara Markovica St, Kragujevac 34000, Sumadija, Serbia. milicaborovcanin@medf.kg.ac.rs
Key Words	Galectin-3; Schizophrenia; Metabolic syndrome; Insulin resistance; Cognition; Antipsychotics
Core Tip	Atypical antipsychotic use could be associated with undesired metabolic effects. In this context, glycosylation has become a new target of investigation of schizophrenia pathophysiology. As a glycan, galectin-3 (Gal-3) might be involved in the inflammation-insulin resistance-obesity cascade in schizophrenia, leading to cognitive changes. Eliminating Gal-3 influence may be beneficial in preserving cognition and reestablishing metabolic balance.
Publish Date	2021-10-13 08:37
Citation	Borovcanin MM, Vesic K, Jovanovic M, Mijailovic NR. Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview. World J Diabetes 2021; 12(10): 1731-1739
URL	https://www.wjgnet.com/1948-9358/full/v12/i10/1731.htm
DOI	https://dx.doi.org/10.4239/wjd.v12.i10.1731

Full Article (PDF)	WJD-12-1731.pdf
Full Article (Word)	WJD-12-1731.docx
Manuscript File	69392-Review-FilipodiaCL.docx
Answering Reviewers	69392-Answering reviewers.pdf
Audio Core Tip	69392-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	69392-Conflict-of-interest statement.pdf
Copyright License Agreement	69392-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	69392-Language certificate.pdf
Peer-review Report	69392-Peer-review(s).pdf
Scientific Misconduct Check	69392-Bing-W JJ-2.png
Scientific Misconduct Check	69392-Scientific misconduct check.pdf
Scientific Editor Work List	69392-Scientific editor work list.pdf
CrossCheck Report	69392-CrossCheck report.pdf